Marksans Pharma

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue497.48496.99510.13550.24590.93
Expenses418.28392.81413.31436.47478.27
EBITDA94.29120.55112.06132.94137.82
EBIT81.55106.6198.41115.40115.82
Profit Before Tax79.21104.1796.83113.77112.66
Net Profit62.3182.7170.4483.8582.97
Financial Ratios
Operating Profit Margin19.65%24.81%22.41%25.03%23.51%
Net Profit Margin13.22%16.86%13.73%15.72%14.20%
Earning Per Share (Diluted)1.561.971.521.841.84
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.7.4
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ